Abbott (NYSE: ABT) today announced that its latest generation of sensor-based glucose monitoring technology, the FreeStyle ...

Abbott and Beta Bionics are collaborating to integrate Abbott’s upcoming dual glucose-ketone sensor with Beta’s iLet Bionic ...

Abbott's mixed reality technology helps distract blood donors and reduce their anxiety levels. This can help encourage young ...

Abbott’s ABT diversified business portfolio appears to be well-positioned to drive continued momentum in 2025. The stock carries a Zacks Rank #2 (Buy) currently. Factors Driving ABT Shares Within ...

The American Diabetes Association, now endorses automated insulin delivery (AID) systems as the leading approach for ...

The strategy and product exec said Tandem aims to give patients options and reach more people who haven’t yet used insulin ...

The American Diabetes Association's McCormick Place event was also a bit of a coming out party for North Chicago-based Abbott ...

Beta Bionics, Inc. BBNX recently entered into a strategic agreement with Abbott Laboratories ABT to integrate its iLet Bionic ...

Control-IQ+ is easy to start, use, and personalize, and this latest integration works with the FreeStyle Libre 3 Plus sensor and extends its benefits to even more people with diabetes.

SAN DIEGO-- (BUSINESS WIRE)--Jun 20, 2025--Tandem Diabetes Care Announces t:slim X2™ Insulin Pump Compatibility with Abbott’s FreeStyle Libre® 3 Plus Sensor in the United States ...

IRVINE, Calif., June 19, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc., a pioneering leader in the development of advanced diabetes management solutions, announced its intention to integrate its iLet ...